Abstract:Mutations in the phospholipase A2 Group 6 (PLA2G6) gene have been identified in autosomal recessive neurodegenerative diseases classified as infantile neuroaxonal dystrophy and neurodegeneration with brain iron accumulation. Recently, PLA2G6 was also reported as the causative gene for early-onset PARK14-linked dystonia-parkinsonism.To address whether PLA2G6 mutations are also an important cause of PD, we screened sequence variants of PLA2G6 in 250 PD patients and 550 controls in a Chinese Han populations. We identified four sequence changes: a coding synonymous c.1959T>A transition of exon13 in one patient, two missense mutations c.1966C>G in exon13 and c.2077C>G in exon14 in two different patients, which caused two amino acids change Leu656Val and Leu693Val respectively. We also found a frame-shift mutation P.His597fx69 in exon 12 in one patient. These four rare variants were not represented in 550 control individuals. Furthermore, we found that WT PLA2G6 enzyme hydrolyzed phospholipids while mutant PLA2G6 with P.His597fx69 frame-shift caused loss of enzyme activity, exhibiting less than 6% of the specific activity in phospholipase assays compared to that of WT PLA2G6. Mutant PLA2G6 with Leu656Val and Leu693Val decreased their activity by 45% and 35% in phospholipase assay respectively.We identified four rare PLA2G6 mutations in 250 PD patients, enlarging the spectrum of PLA2G6 mutations in PD. Although PLA2G6 mutations account for only a small fraction of PD patients in Chinese populations, these mutations impair catalytic activity of their phospholipids-hydrolyzing function. These results indicate that PLA2G6 mutations maybe PD-causing in Chinese Han populations.

Autosomal dominant Parkinson's disease caused by the recently identified LRRK2 N1437D mutation in a Chinese family: Clinical features, imaging findings, and functional impact

Clinical and Functional Evidence for the Pathogenicity of the LRRK2 P.arg1067gln Variant

The LRRK2 gene is mutated in a Chinese autosomal-dominant Parkinson's disease family.

[Genetic Study of a Parkinson's Disease Pedigree Caused by Compound Heterozygous Mutations in PARK2 Gene].

LRP10 in Autosomal-Dominant Parkinson's Disease.

Four novel rare mutations of PLA2G6 in Chinese population with Parkinson's disease.

Genetic Analysis of the CHCHD2 Gene in a Cohort of Chinese Patients with Parkinson Disease.

Analysis of Rare Variants of Autosomal‐dominant Genes in a Chinese Population with Sporadic Parkinson’s Disease

The Heterozygous R1441C Mutation of Leucine-Rich Repeat Kinase 2 Gene in a Chinese Patient with Parkinson Disease: A Five-Year Follow-Up and Literatures Review

Clinical Features and Mutation Analysis of LRRK2 Gene in Patients with Autosomal Dominant Familial Parkinson's Disease

Genetic Screening for Mutations in the Nrdp1 Gene in Parkinson Disease Patients in a Chinese Population

Genetic Analysis of LRRK2 in Parkinson's Disease in Han Chinese Population.

Genetic Analysis of ATP13A2, PLA2G6 and FBXO7 in a Cohort of Chinese Patients with Early-Onset Parkinson's Disease.

LRRK2 R1628P variant is a risk factor of Parkinson's disease among Han-Chinese from mainland China.

Lrrk2 Pro755leu Variant in Ethnic Chinese Population with Parkinson'S Disease

Confirmation of LRRK2 S1647T Variant As a Risk Factor for Parkinson's Disease in Southern China.

Genetic Analysis of LRRK2 A419V Variant in Ethnic Chinese

Lrrk2 Gly2385arg Variant is A Risk Factor of Parkinson'S Disease among Han-Chinese from Mainland China

Correlation between LRRK2 gene polymorphism sites S1647T and R1398H and Parkinson's disease in a Chinese Han population

Multiple LRRK2 variants modulate risk of Parkinson disease: a Chinese multicenter study.

Effect of a Leucine-rich Repeat Kinase 2 Variant on Motor and Non-motor Symptoms in Chinese Parkinson's Disease Patients.